(NXPI) NXP Semiconductors - Overview
Exchange: NASDAQ •
Country: Netherlands •
Currency: USD •
Type: Common Stock •
ISIN: NL0009538784
Stock: Processors, Connectivity, Sensors, Security, RF
Total Rating 41
Risk 69
Buy Signal -0.90
| Risk 5d forecast | |
|---|---|
| Volatility | 45.8% |
| Relative Tail Risk | -2.49% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.05 |
| Alpha | -30.66 |
| Character TTM | |
|---|---|
| Beta | 1.700 |
| Beta Downside | 1.750 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.47% |
| CAGR/Max DD | 0.15 |
EPS (Earnings per Share)
Revenue
Description: NXPI NXP Semiconductors March 05, 2026
NXP Semiconductors N.V. (NXPI) is a Dutch semiconductor company operating globally, with significant presence in Asia, Europe, and North America.
The company designs and manufactures a broad range of semiconductor products, including microcontrollers, application processors, wireless connectivity solutions (e.g., NFC, UWB, Bluetooth), analog and interface products, RF devices, and various sensors.
These products are critical components in diverse applications, notably automotive, industrial IoT, mobile devices, and communication infrastructure. The semiconductor industry is characterized by high R&D investment and rapid technological advancement.
NXP distributes its products through direct sales and independent distributors, a common business model in the electronics component sector.
For further detailed analysis of NXPs financial performance and market position, consider exploring ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 2.02b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 1.96 > 1.0 |
| NWC/Revenue: 33.08% < 20% (prev 33.35%; Δ -0.27% < -1%) |
| CFO/TA 0.11 > 3% & CFO 2.82b > Net Income 2.02b |
| Net Debt (8.96b) to EBITDA (3.92b): 2.28 < 3 |
| Current Ratio: 2.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (254.1m) vs 12m ago -1.46% < -2% |
| Gross Margin: 54.58% > 18% (prev 0.56%; Δ 5402 % > 0.5%) |
| Asset Turnover: 48.17% > 50% (prev 51.73%; Δ -3.56% > 0%) |
| Interest Coverage Ratio: 6.37 > 6 (EBITDA TTM 3.92b / Interest Expense TTM 485.0m) |
Altman Z'' 1.56
| A: 0.15 (Total Current Assets 7.94b - Total Current Liabilities 3.88b) / Total Assets 26.56b |
| B: -0.05 (Retained Earnings -1.35b / Total Assets 26.56b) |
| C: 0.12 (EBIT TTM 3.09b / Avg Total Assets 25.47b) |
| D: -0.08 (Book Value of Equity -1.35b / Total Liabilities 16.11b) |
| Altman-Z'' Score: 1.56 = BB |
Beneish M -2.99
| DSRI: 1.05 (Receivables 1.05b/1.03b, Revenue 12.27b/12.61b) |
| GMI: 1.03 (GM 54.58% / 55.95%) |
| AQI: 1.04 (AQ_t 0.59 / AQ_t-1 0.57) |
| SGI: 0.97 (Revenue 12.27b / 12.61b) |
| TATA: -0.03 (NI 2.02b - CFO 2.82b) / TA 26.56b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of NXPI shares?
As of March 07, 2026, the stock is trading at USD 201.74 with a total of 3,077,251 shares traded.
Over the past week, the price has changed by -11.13%, over one month by -10.07%, over three months by -11.51% and over the past year by -4.17%.
Over the past week, the price has changed by -11.13%, over one month by -10.07%, over three months by -11.51% and over the past year by -4.17%.
Is NXPI a buy, sell or hold?
NXP Semiconductors has received a consensus analysts rating of 4.41.
Therefore, it is recommended to buy NXPI.
- StrongBuy: 19
- Buy: 7
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NXPI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 262.1 | 29.9% |
| Analysts Target Price | 262.1 | 29.9% |
NXPI Fundamental Data Overview March 06, 2026
P/E Trailing = 27.2506
P/E Forward = 16.0772
P/S = 4.4564
P/B = 5.6479
P/EG = 0.699
Revenue TTM = 12.27b USD
EBIT TTM = 3.09b USD
EBITDA TTM = 3.92b USD
Long Term Debt = 10.97b USD (from longTermDebt, last quarter)
Short Term Debt = 1.25b USD (from shortTermDebt, last quarter)
Debt = 12.22b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.96b USD (from netDebt column, last quarter)
Enterprise Value = 63.63b USD (54.68b + Debt 12.22b - CCE 3.27b)
Interest Coverage Ratio = 6.37 (Ebit TTM 3.09b / Interest Expense TTM 485.0m)
EV/FCF = 24.06x (Enterprise Value 63.63b / FCF TTM 2.65b)
FCF Yield = 4.16% (FCF TTM 2.65b / Enterprise Value 63.63b)
FCF Margin = 21.56% (FCF TTM 2.65b / Revenue TTM 12.27b)
Net Margin = 16.47% (Net Income TTM 2.02b / Revenue TTM 12.27b)
Gross Margin = 54.58% ((Revenue TTM 12.27b - Cost of Revenue TTM 5.57b) / Revenue TTM)
Gross Margin QoQ = 53.58% (prev 56.32%)
Tobins Q-Ratio = 2.40 (Enterprise Value 63.63b / Total Assets 26.56b)
Interest Expense / Debt = 0.88% (Interest Expense 108.0m / Debt 12.22b)
Taxrate = 21.87% (131.0m / 599.0m)
NOPAT = 2.41b (EBIT 3.09b * (1 - 21.87%))
Current Ratio = 2.05 (Total Current Assets 7.94b / Total Current Liabilities 3.88b)
Debt / Equity = 1.22 (Debt 12.22b / totalStockholderEquity, last quarter 10.06b)
Debt / EBITDA = 2.28 (Net Debt 8.96b / EBITDA 3.92b)
Debt / FCF = 3.39 (Net Debt 8.96b / FCF TTM 2.65b)
Total Stockholder Equity = 9.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.93% (Net Income 2.02b / Total Assets 26.56b)
RoE = 20.73% (Net Income TTM 2.02b / Total Stockholder Equity 9.75b)
RoCE = 14.91% (EBIT 3.09b / Capital Employed (Equity 9.75b + L.T.Debt 10.97b))
RoIC = 11.24% (NOPAT 2.41b / Invested Capital 21.48b)
WACC = 10.08% (E(54.68b)/V(66.90b) * Re(12.18%) + D(12.22b)/V(66.90b) * Rd(0.88%) * (1-Tc(0.22)))
Discount Rate = 12.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.20%
[DCF] Terminal Value 72.85% ; FCFF base≈2.37b ; Y1≈2.66b ; Y5≈3.54b
[DCF] Fair Price = 135.2 (EV 43.12b - Net Debt 8.96b = Equity 34.17b / Shares 252.7m; r=10.08% [WACC]; 5y FCF grow 14.20% → 2.90% )
EPS Correlation: -60.03 | EPS CAGR: -0.16% | SUE: 1.28 | # QB: 1
Revenue Correlation: -41.84 | Revenue CAGR: 1.65% | SUE: 2.04 | # QB: 3
EPS next Quarter (2026-06-30): EPS=3.21 | Chg7d=-0.000 | Chg30d=-0.002 | Revisions Net=+3 | Analysts=22
EPS current Year (2026-12-31): EPS=13.93 | Chg7d=+0.005 | Chg30d=+0.134 | Revisions Net=+13 | Growth EPS=+18.0% | Growth Revenue=+10.4%
EPS next Year (2027-12-31): EPS=16.77 | Chg7d=+0.019 | Chg30d=+0.109 | Revisions Net=+9 | Growth EPS=+20.3% | Growth Revenue=+10.2%
[Analyst] Revisions Ratio: +0.16 (11 Up / 8 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.5% (Discount Rate 12.2% - Earnings Yield 3.7%)
[Growth] Growth Spread = +3.3% (Analyst 11.8% - Implied 8.5%)
P/E Forward = 16.0772
P/S = 4.4564
P/B = 5.6479
P/EG = 0.699
Revenue TTM = 12.27b USD
EBIT TTM = 3.09b USD
EBITDA TTM = 3.92b USD
Long Term Debt = 10.97b USD (from longTermDebt, last quarter)
Short Term Debt = 1.25b USD (from shortTermDebt, last quarter)
Debt = 12.22b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.96b USD (from netDebt column, last quarter)
Enterprise Value = 63.63b USD (54.68b + Debt 12.22b - CCE 3.27b)
Interest Coverage Ratio = 6.37 (Ebit TTM 3.09b / Interest Expense TTM 485.0m)
EV/FCF = 24.06x (Enterprise Value 63.63b / FCF TTM 2.65b)
FCF Yield = 4.16% (FCF TTM 2.65b / Enterprise Value 63.63b)
FCF Margin = 21.56% (FCF TTM 2.65b / Revenue TTM 12.27b)
Net Margin = 16.47% (Net Income TTM 2.02b / Revenue TTM 12.27b)
Gross Margin = 54.58% ((Revenue TTM 12.27b - Cost of Revenue TTM 5.57b) / Revenue TTM)
Gross Margin QoQ = 53.58% (prev 56.32%)
Tobins Q-Ratio = 2.40 (Enterprise Value 63.63b / Total Assets 26.56b)
Interest Expense / Debt = 0.88% (Interest Expense 108.0m / Debt 12.22b)
Taxrate = 21.87% (131.0m / 599.0m)
NOPAT = 2.41b (EBIT 3.09b * (1 - 21.87%))
Current Ratio = 2.05 (Total Current Assets 7.94b / Total Current Liabilities 3.88b)
Debt / Equity = 1.22 (Debt 12.22b / totalStockholderEquity, last quarter 10.06b)
Debt / EBITDA = 2.28 (Net Debt 8.96b / EBITDA 3.92b)
Debt / FCF = 3.39 (Net Debt 8.96b / FCF TTM 2.65b)
Total Stockholder Equity = 9.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.93% (Net Income 2.02b / Total Assets 26.56b)
RoE = 20.73% (Net Income TTM 2.02b / Total Stockholder Equity 9.75b)
RoCE = 14.91% (EBIT 3.09b / Capital Employed (Equity 9.75b + L.T.Debt 10.97b))
RoIC = 11.24% (NOPAT 2.41b / Invested Capital 21.48b)
WACC = 10.08% (E(54.68b)/V(66.90b) * Re(12.18%) + D(12.22b)/V(66.90b) * Rd(0.88%) * (1-Tc(0.22)))
Discount Rate = 12.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.20%
[DCF] Terminal Value 72.85% ; FCFF base≈2.37b ; Y1≈2.66b ; Y5≈3.54b
[DCF] Fair Price = 135.2 (EV 43.12b - Net Debt 8.96b = Equity 34.17b / Shares 252.7m; r=10.08% [WACC]; 5y FCF grow 14.20% → 2.90% )
EPS Correlation: -60.03 | EPS CAGR: -0.16% | SUE: 1.28 | # QB: 1
Revenue Correlation: -41.84 | Revenue CAGR: 1.65% | SUE: 2.04 | # QB: 3
EPS next Quarter (2026-06-30): EPS=3.21 | Chg7d=-0.000 | Chg30d=-0.002 | Revisions Net=+3 | Analysts=22
EPS current Year (2026-12-31): EPS=13.93 | Chg7d=+0.005 | Chg30d=+0.134 | Revisions Net=+13 | Growth EPS=+18.0% | Growth Revenue=+10.4%
EPS next Year (2027-12-31): EPS=16.77 | Chg7d=+0.019 | Chg30d=+0.109 | Revisions Net=+9 | Growth EPS=+20.3% | Growth Revenue=+10.2%
[Analyst] Revisions Ratio: +0.16 (11 Up / 8 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.5% (Discount Rate 12.2% - Earnings Yield 3.7%)
[Growth] Growth Spread = +3.3% (Analyst 11.8% - Implied 8.5%)